Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
26.41
-1.59 (-5.68%)
Jun 20, 2025, 11:58 AM - Market open

Caris Life Sciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
31.263.9556.4107.19
Short-Term Investments
2.232.265.18302.43
Cash & Short-Term Investments
33.4366.15121.59409.62
Cash Growth
--45.59%-70.32%-
Receivables
80.1788.2455.340.23
Inventory
36.5539.574946.96
Prepaid Expenses
11.9213.5611.7713.36
Restricted Cash
1.51.493.613.95
Other Current Assets
7.656.711.361.93
Total Current Assets
171.23215.73242.61516.04
Property, Plant & Equipment
61.65102.77147.51179.19
Goodwill
19.3419.3419.3419.34
Other Long-Term Assets
39.365.893.432.85
Total Assets
291.58343.73412.9717.42
Accounts Payable
24.2327.7926.6827.27
Accrued Expenses
64.5563.9955.6851.11
Current Portion of Long-Term Debt
6060-52.04
Current Portion of Leases
6.116.176.595.05
Current Unearned Revenue
7.667.475.681.43
Other Current Liabilities
--0.51-
Total Current Liabilities
162.55165.4295.14136.91
Long-Term Debt
316.4319.2166.11169.09
Long-Term Leases
37.3138.8944.4144.69
Other Long-Term Liabilities
129.0797.41126.91114.68
Total Liabilities
645.34620.92432.57465.36
Common Stock
0.150.140.140.14
Retained Earnings
-2,583-2,472-2,119-1,679
Treasury Stock
-16.92-0.33-0.33-0.33
Comprehensive Income & Other
0.25-26.25-25.48-23.27
Total Common Equity
-2,600-2,499-2,145-1,702
Shareholders' Equity
-353.75-277.19-19.67252.06
Total Liabilities & Equity
291.58343.73412.9717.42
Total Debt
419.83424.26217.11270.87
Net Cash (Debt)
-386.4-358.11-95.52138.75
Net Cash Per Share
-2.72-2.52-0.681.04
Filing Date Shares Outstanding
140.95140.95140.46133.46
Total Common Shares Outstanding
140.95146.02140.46133.46
Working Capital
8.6850.31147.47379.14
Book Value Per Share
-18.45-17.11-15.27-12.75
Tangible Book Value
-2,619-2,518-2,164-1,721
Tangible Book Value Per Share
-18.58-17.25-15.41-12.90
Machinery
211.38233.39224.65210.05
Leasehold Improvements
63.2963.0466.5863.1
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q